Intermediates for 1,3-disubstituted piperidine compounds as neur

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D21122

Patent

active

046237283

ABSTRACT:
Certain novel 1-(substituted-alkyl)-3-(3-hydroxyphenyl)piperidine compounds, and the pharmeceutically-acceptable acid-addition salts thereof, possess pharmaceutical activity as neuroleptic agents, and they are useful for treating psychotic disorders, e.g. schizophrenia, in human subjects. In particular, they are useful for alleviating such symptoms as anxiety, agitation, excessive aggression, tension and social or emotional withdrawal in psychotic patients.
Certain 3-(3-methoxyphenyl)piperidine compounds are useful as chemical intermediates to the aforementioned neuroleptic agents.

REFERENCES:
patent: 4072685 (1978-02-01), Nedelec et al.
patent: 4241071 (1980-12-01), Martin et al.
patent: 4332942 (1982-06-01), Althuis et al.
Julia et al., Bulletin de la Societe Chimique de France, No. 3, pp. 1000-1007 (1968).
Hacksell et al., Journal of Medicinal Chemistry, 24, pp. 1475-1482 (1981).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Intermediates for 1,3-disubstituted piperidine compounds as neur does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intermediates for 1,3-disubstituted piperidine compounds as neur, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermediates for 1,3-disubstituted piperidine compounds as neur will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1618388

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.